| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | A |
| 3. Samples | A |
| 4. Measurand | A |
| 5. Pre-Analytical | A |
| 6. Replicate Analysis | A |
| 7. Steady State | A |
| 8. Outlier Analysis | A |
| 9. Normality | A |
| 10. Variance Homogeneity | A |
| 11. ANOVA | A |
| 12. CI | A |
| 13. No of Results | A |
| 14. Concentrations | A |
| 15. Total Score | A1,2,3,4,5,6,7,8,9,10,11,12,13,14 |
| Comment |
| Parameter | Score |
|---|---|
| Matrix | Serum |
| Measurand | 25-hydroxy vitamin D3 |
| Unit | ug / ug |
| Overall Analytical Principle Method | Chemiluminescence |
| Number of Subjects | 21 |
| Number of Subjects included in BV estimation | |
| Ethinicity | Caucasian |
| Age Mean / Median | |
| Age Min | 18.0 |
| Age Max | 50.0 |
| Age SD | |
| Number of Males | 10 |
| Number of Females | 11 |
| State of Well Being |
Healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 1 |
| Study Duration Units | Month |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 1 |
| Interval Units | Week |
| Sampling Times | Start Time:
8:30
End Time: 10:00 |
| Number of Samples | 5 |
| Average Number of Samples Used for BV Estimation | 5.0 |
| Average Number of Replicates | 2.0 |
| Estimates of CVi | 8.2 |
| Calculated Confidence Intervals of CVi | Lower: 7.02, Upper: 9.78 |
| Estimates of CVg | 54.9 |
| Calculated Confidence Intervals of CVg | Lower: 42.17, Upper: 78.55 |
| Analytical CV | 3.4 |
| Calculated Confidence Intervals of Analytical CV | Lower: 3.00, Upper: 3.93 |
| Measurand Mean | |
| Measurand Min | |
| Measurand Max | |
| Measurand SD |